← Back
F 10b5-1 Plan

$ Value

$19K

Shares

1,340

Price

$14

Filed

Mar 4

Insider

Name

Morrell Martha

Title

CHIEF MEDICAL OFFICER

CIK

0001855616

Roles

Officer

Transaction Details

Transaction Date

2026-03-03

Code

F

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

48,624

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.83 to $16.26, inclusive. The reporting person undertakes to provide the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form. | Represents the number of shares withheld by the Issuer on March 3, 2026 to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit award.

Filing Info

Accession No.

0001855616-26-000007

Form Type

4

Issuer CIK

0001528287

Morrell Martha's History

Date Ticker Type Value
2026-03-24 NPCE F $18K
2026-03-03 NPCE F $19K
2026-02-27 NPCE F $5K
2026-02-20 NPCE F $49K
2025-12-15 NPCE $399K
2025-12-03 NPCE F $22K
2025-11-27 NPCE F $6K
2025-11-20 NPCE F $41K
2025-09-03 NPCE F $13K
2025-08-27 NPCE F $3K

Other Insiders at NPCE (90d)

Insider Bought Sold Last
LACOB JOSEPH 2026-03-20
Geiger Uri 2026-03-20
Becker Joel
CHIEF EXECUTIVE OFFICER
2026-03-03
Morrell Martha
CHIEF MEDICAL OFFICER
$399K 2026-03-24